NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Wednesday that its revenues in the second quarter of 2009 were down 12 percent compared with the 2008 period, and it saw a profit swing to a loss.
The Omaha, Neb.-based genetic test provider said that it brought in revenues of $5.5 million for the three-month period ended June 30, compared with $6.2 million a year ago.
Transgenomic posted a loss of $730,000, or $.01 per share, compared to a net profit of $101,000, or $.00 per share, in the second quarter of 2008.